Clinical Trial: Risk-ADAPTed Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation
Study Status: Completed
Recruit Status: RECRUITING
Condition: Allogeneic Hematopoietic Stem Cell Transplantation
Study Type: INTERVENTIONAL
Official Title: Risk-ADAPTed Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation (ADAPT)
Brief Summary:
This is a prospective, single-arm, phase II study.Patients will be treated with an allogeneic stem cell transplantation (AHSCT) using fludarabine, melphalan and total body irradiation (TBI) conditioning with different melphalan and TBI doses based on patient- and disease-related risk.
Read more